|
|
Thorax. 1991 October; 46(10): 722–726. | PMCID: PMC463391 |
Diagnostic value of lung clearance of 99mTc DTPA compared with other non-invasive investigations in Pneumocystis carinii pneumonia in AIDS. D S Robinson, D A Cunningham, S Dave, J Fleming, and D M Mitchell Department of Respiratory Medicine, St Mary's Hospital, London. Abstract Various non-invasive investigations were carried out in patients infected with HIV who had respiratory symptoms with and without pneumocystis pneumonia (with pneumonia, n = 13 (five smokers); without pneumonia, n = 22 (13 smokers]. These included chest radiography; lung function tests (forced expiratory volume in one second, forced vital capacity; transfer factor and coefficient for carbon monoxide); arterial blood gas tensions; arterial oxygen saturation at rest and on exercise; and lung clearance of diethylenetriaminepenta-acetic acid labelled with technetium-99m (99mTc DTPA). The effect of scan time (seven v 45 minutes from peak counts) and subtraction of background counts were examined. There were no significant differences between the two groups in lung function tests or arterial blood gas tensions at rest. The median clearance half time of inhaled 99mTc DTPA for the first seven minutes from peak counts was 7.2 minutes for patients with pneumocystis pneumonia and 22 minutes for those without. The median arterial oxygen desaturation on exercise was 5% in patients with pneumocystis pneumonia and 2% in those without. 99mTc DTPA lung clearance was better than the other non-invasive tests in discriminating pneumocystis pneumonia from other pulmonary disorders in patients positive for HIV. A short scan time of seven minutes was as sensitive and specific as the longer scan time of 45 minutes, and this allows the clearance of 99mTc DTPA to become a rapid screening test. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (814K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Greenspan JS, Mastrucci MT, Leggott PJ, Freese UK, De Souza YG, Scott GB, Greenspan D. Hairy leukoplakia in a child. AIDS. 1988 Apr;2(2):143. [PubMed]
- Mitchell DM. Diagnostic problems in AIDS and the lung. Respir Med. 1989 Jan;83(1):9–14. [PubMed]
- Montgomery AB, Debs RJ, Luce JM, Corkery KJ, Turner J, Brunette EN, Lin ET, Hopewell PC. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987 Aug 29;2(8557):480–483. [PubMed]
- Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA. 1988 Feb 26;259(8):1185–1189. [PubMed]
- Miller RF, Millar AB, Weller IV, Semple SJ. Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Thorax. 1989 Jul;44(7):559–564. [PMC free article] [PubMed]
- Langford JA, Lewis CA, Gellert AR, Tolfree SE, Rudd RM. Pulmonary epithelial permeability: vascular background effects on whole lung and regional half-time values. Nucl Med Commun. 1986 Mar;7(3):183–190. [PubMed]
- Suster B, Akerman M, Orenstein M, Wax MR. Pulmonary manifestations of AIDS: review of 106 episodes. Radiology. 1986 Oct;161(1):87–93. [PubMed]
- Engelberg LA, Lerner CW, Tapper ML. Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome. Am Rev Respir Dis. 1984 Oct;130(4):689–694. [PubMed]
- Coleman DL, Dodek PM, Golden JA, Luce JM, Golden E, Gold WM, Murray JF. Correlation between serial pulmonary function tests and fiberoptic bronchoscopy in patients with Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Respir Dis. 1984 Mar;129(3):491–493. [PubMed]
- Shaw RJ, Roussak C, Forster SM, Harris JR, Pinching AJ, Mitchell DM. Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax. 1988 Jun;43(6):436–440. [PMC free article] [PubMed]
- Rosen MJ, Tow TW, Teirstein AS, Chuang MT, Marchevsky A, Bottone EJ. Diagnosis of pulmonary complications of the acquired immune deficiency syndrome. Thorax. 1985 Aug;40(8):571–575. [PMC free article] [PubMed]
- Stover DE, White DA, Romano PA, Gellene RA, Robeson WA. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med. 1985 Mar;78(3):429–437. [PubMed]
- Smith DE, McLuckie A, Wyatt J, Gazzard B. Severe exercise hypoxaemia with normal or near normal X-rays: a feature of Pneumocystis carinii infection. Lancet. 1988 Nov 5;2(8619):1049–1051. [PubMed]
- Yoneda K, Walzer PD. Interaction of Pneumocystis carinii with host lungs: an ultrastructural study. Infect Immun. 1980 Aug;29(2):692–703. [PMC free article] [PubMed]
- Jones JG, Minty BD, Royston D. The physiology of leaky lungs. Br J Anaesth. 1982 Jul;54(7):705–721. [PubMed]
- O'Doherty MJ, Page CJ, Bradbeer CS, Shahmanesh M, Edwards A, Barlow D, Nunan TO, Bateman NT. The place of lung 99mTc DTPA aerosol transfer in the investigation of lung infections in HIV positive patients. Respir Med. 1989 Sep;83(5):395–401. [PubMed]
- Jones JG, Minty BD, Lawler P, Hulands G, Crawley JC, Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet. 1980 Jan 12;1(8159):66–68. [PubMed]
- Mitchell DM, Solomon MA, Tolfree SE, Short M, Spiro SG. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax. 1987 Jun;42(6):457–461. [PMC free article] [PubMed]
- O'Doherty MJ, Page CJ, Croft DN, Bateman NT. Lung 99Tcm-DTPA transfer: a method for background correction. Nucl Med Commun. 1985 Apr;6(4):209–215. [PubMed]
|
See commentary "